Netherton syndrome with extensive skin peeling and failure to thrive due to a homozygous frameshift mutation in SPINK5

被引:15
作者
Geyer, AS
Ratajczak, P
Pol-Rodriguez, MP
Millar, WS
Garzon, M
Richard, G
机构
[1] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA
[3] Columbia Univ, Med Ctr, Dept Dermatol, New York, NY USA
[4] Columbia Univ, Med Ctr, Dept Pediat, New York, NY USA
[5] Columbia Univ, Dept Radiol, New York, NY USA
关键词
Netherton syndrome; peeling skin syndrome; exfoliative erythroderma; failure to thrive; serine protease inhibitor;
D O I
10.1159/000084755
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Netherton syndrome (NTS) is a rare autosomal recessive multisystem disorder characterized by congenital erythroderma and ichthyosis, hair shaft abnormalities and immune dysregulation. The disorder is caused by deleterious mutations in the SPINK5 gene, encoding the serine protease inhibitor LEKTI. Objective: Our objective was to investigate if the erythrodermic variant of peeling skin syndrome is also caused by SPINK5 mutations and to study the consequences of the disease on infantile brain development. Methods: In an infant with extensive erythroderma, peeling skin and failure to thrive, we analyzed the SPINK5 gene for pathogenic mutations by direct DNA sequencing and performed repeated brain MRI studies with diffusion-weighted imaging. Results: We identified a homozygous 4-base-pair insertion in exon 5 of SPINK5, which introduces a premature termination codon and appears to be a common mutation among West Indies islanders. MRI analyses revealed a persistent diffuse volume loss. Conclusion: Our results confirm that early truncation mutations of the coding sequence of SPINK5 produce a severe phenotype and that generalized peeling skin is one of the manifestations of NTS. We further demonstrate for the first time that NTS may be associated with MRI abnormalities indicative of a permanent tissue injury of the brain. Copyright (c) 2005 S. Karger AG, Basel.
引用
收藏
页码:308 / 314
页数:7
相关论文
共 21 条
  • [11] Characterization and expression analysis of the Spink5 gene, the mouse ortholog of the defective gene in Netherton syndrome
    Galliano, MF
    Roccasecca, RM
    Descargues, P
    Micheloni, A
    Levy, E
    Zambruno, G
    D'Alessio, M
    Hovnanian, A
    GENOMICS, 2005, 85 (04) : 483 - 492
  • [12] A viable mouse model for Netherton syndrome based on mosaic inactivation of the Spink5 gene
    Kasparek, Petr
    Ileninova, Zuzana
    Haneckova, Radka
    Kanchev, Ivan
    Jenickova, Irena
    Sedlacek, Radislav
    BIOLOGICAL CHEMISTRY, 2016, 397 (12) : 1287 - 1292
  • [13] SPINK5 and Netherton syndrome:: Novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases
    Raghunath, M
    Tontsidou, L
    Oji, V
    Aufenvenne, K
    Schürmeyer-Horst, F
    Jayakumar, A
    Ständer, H
    Smolle, J
    Clayman, GL
    Traupe, H
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (03) : 474 - 483
  • [14] Netherton syndrome in two Japanese siblings with a novel mutation in the SPINK5 gene:: immunohistochemical studies of LEKTI and other epidermal molecules
    Shimomura, Y
    Sato, N
    Kariya, N
    Takatsuka, S
    Ito, M
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (05) : 1026 - 1030
  • [15] Successful infliximab treatment in siblings with Netherton syndrome: Unveiling a novel SPINK5 gene variant and literature review
    Salici, Nazmiye Selin
    Ozcanli, Adil
    Rasulova, Gunel
    Basak, Ayse Nazli
    Tekgul, Seyma
    Vural, Secil
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (03) : e45 - e49
  • [16] SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7
    Wang, Shirley
    Olt, Sabine
    Schoefmann, Nicole
    Stuetz, Anton
    Winiski, Anthony
    Wolff-Winiski, Barbara
    EXPERIMENTAL DERMATOLOGY, 2014, 23 (07) : 524 - 526
  • [17] Netherton syndrome caused by compound heterozygous mutation, c.80A>G mutation in SPINK5 and large-sized genomic deletion mutation, and successful treatment of intravenous immunoglobulin
    Zhang, Zhen
    Pan, Chaolan
    Wei, Ruoqu
    Li, Huaguo
    Yang, Yijun
    Chen, Jiawen
    Li, Ming
    Yao, Zhirong
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2021, 9 (03):
  • [18] A compound synonymous mutation c.474G>A with p.Arg578X mutation in SPINK5 causes splicing disorder and mild phenotype in Netherton syndrome
    Numata, Sanae
    Teye, Kwesi
    Krol, Rafal P.
    Okamatsu, Yuki
    Hashikawa, Keiko
    Matsuda, Mitsuhiro
    Fortugno, Paola
    Di Zenzo, Giovanni
    Castiglia, Daniele
    Zambruno, Giovanna
    Hamada, Takahiro
    Hashimoto, Takashi
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (07) : 568 - 570
  • [19] Comparative analyses of Netherton syndrome patients and Spink5 conditional knock-out mice uncover disease-relevant pathways
    Petrova, Evgeniya
    Lopez-Gay, Jesus Maria
    Fahrner, Matthias
    Leturcq, Florent
    de Villartay, Jean-Pierre
    Barbieux, Claire
    Gonschorek, Patrick
    Tsoi, Lam C.
    Gudjonsson, Johann E.
    Schilling, Oliver
    Hovnanian, Alain
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [20] Netherton Syndrome with a Novel Likely Pathogenic Variant c.420del (p.Ser141ProfsTer5) in SPINK5 Gene: A Case Report
    Kovacheva, Katya
    Kamburova, Zornitza
    Vasilev, Preslav
    Yordanova, Ivelina
    CASE REPORTS IN DERMATOLOGY, 2024, 16 (01): : 47 - 54